Travere Therapeutics, Inc. TVTX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s asset turnover?
- Travere Therapeutics, Inc. (TVTX) reported asset turnover of 1× in Q1 2026.
- How has Travere Therapeutics, Inc.'s asset turnover changed year-over-year?
- Travere Therapeutics, Inc.'s asset turnover increased by 115.3% year-over-year, from 0.5× to 1×.
- What is the long-term trend for Travere Therapeutics, Inc.'s asset turnover?
- Over 4 years (2020 to 2025), Travere Therapeutics, Inc.'s asset turnover has grown at a 25.8% compound annual growth rate (CAGR), from 0.3× to 0.8×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.